TCL Archive In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial April 29, 1988
TCL Archive GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL July 26, 2013
TCL Archive NCI Community Cancer Centers RFP Issued; Advisors Criticize Project Structure. November 10, 2006